STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV: 25,000‑share resale notice and multiple 10b5‑1 sales (NASDAQ: CRWV)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Company submitted a Form 144 notice describing proposed sales of common stock totaling 25,000 shares with an aggregate value of $2,948,750.00 as shown in the filing. The filing lists multiple 10b5-1 sale executions by related holders across several dates in 2026, including repeated entries for the same trusts and individuals.

The filing itemizes many completed 10b5-1 sales by named holders (dates and per‑transaction share counts and proceeds are listed), and identifies the broker/dealer as Morgan Stanley Smith Barney LLC with an indicated NASDAQ listing. The filing is a notice of proposed or recent resale activity rather than an issuance of new shares.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists proposed/resale activity and multiple 10b5-1 executions by related holders.

The filing documents a proposed sale notice of 25,000 shares with an aggregate value of $2,948,750.00 and separately lists numerous completed 10b5-1 sales by named trusts and individuals across 2026. The broker/dealer identified is Morgan Stanley Smith Barney LLC.

Timing and method details for many entries are explicit by date and per‑transaction proceeds; cash‑flow recipients are the selling holders per the listed sales. Regulatory treatment: this is disclosure/compliance paperwork for resale under Rule 144/Regulation, not an issuer primary offering.

Registered/resale shares 25,000 shares Form 144 header
Aggregate value shown $2,948,750.00 Form 144 header
Outstanding/other numeric field 447,573,939 Number appearing in header row (context not labeled as registered)
Broker/dealer Morgan Stanley Smith Barney LLC Form 144 header
Example executed sale 200,000 shares / $23,186,400.00 10b5-1 sale entry dated <date> 04/20/2026
Example executed sale 144,000 shares / $15,450,595.20 10b5-1 sale entry dated <date> 06/15/2026
Form 144 regulatory
"Form 144 header listing proposed resale of 25,000 shares"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 regulatory
"Multiple entries labeled "10b5-1 Sales" with dates and proceeds"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
GRAT financial
"Entries referencing "Canis Major 2025 GRAT" among selling holders"
Irrevocable Trust financial
"Holder named "Canis Major 2024 Irrevocable TR LLC" in selling list"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

FAQ

What does the CRWV Form 144 disclose?
It discloses a proposed/resale notice of 25,000 shares with an aggregate value of $2,948,750.00. The filing also lists multiple 10b5-1 sale executions by named holders with dates and per‑transaction proceeds in 2026.

Who is the broker/dealer handling the sales in the filing?
The filing lists Morgan Stanley Smith Barney LLC as the broker/dealer. The broker/dealer address and an NASDAQ listing are shown alongside the registered share and dollar amounts in the Form 144 header.

Are the listed 10b5-1 sales completed or proposed?
The filing itemizes numerous dated 10b5-1 sales showing specific share counts and proceeds on those dates in 2026. Those entries reflect executed sales reported in the filing; the Form 144 line showing 25,000 shares appears as a proposed resale notice.

Which holders appear repeatedly in the Form 144 excerpt?
Repeated selling parties include Brannin McBee, Meghan Bennett, and several related trusts and GRATs (e.g., Canis Major 2025 GRAT, Brannin J. McBee 2022 IRR Trust) listed with multiple dated 10b5-1 sale entries in 2026.

Does the filing register new shares for issuance by the company?
No. The filing lists resale/transfer activity and 10b5-1 sales by holders; it does not describe an issuer primary offering or registration of newly issued shares. It functions as a resale/compliance notice under securities resale rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR